Exabis Library
Welcome to the e-CCO Library!
DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP20: Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP20: Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy Risk
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP21: Time to first treatment with biologic agents for Ulcerative Colitis and Crohn’s Disease across four Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP24: Multi-omic sequencing reveals distinctive gene expression and DNA methylation alterations as potential predictors of primary sclerosing cholangitis development in treatment-naïve paediatric Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP25: Medication use and comorbidities among elderly as compared to younger patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP26: Burden of perianal disease and perianal surgery in Crohn’s disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM